NIBSC - clinical virology standards

Product Number	Description
07/296-006	Influenza Virus (A/Christchurch/1/2003, H1N1) for Nucleic Acid Amplification Techniques
07/298-006	Influenza Virus (A/Wyoming/3/2003, H3N2) for Nucleic Acid Amplification Techniques
07/300-006	Influenza Virus (B/Jiangsu/10/2003) for Nucleic Acid Amplification Techniques
08/118-005	Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques
08/120-006	Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques
08/174-008	Human Coxsackie B4 for Nucleic Acid Amplification Techniques
08/176-005	Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques
08/178-005	Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques
08/180-005	Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques
08/318-007	Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing
08/320-007	Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing
08/322-006	Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing
08/324-005	Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing
09/132-004	Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing
13/168-002	Human Measles Mvi/Moscow Rus/1988 Genotype A Virus for Nucleic Acid Amplification Techniques
15/130-001	Clinical Virology Multiplex I: Immunodeficiency panel working reagent for Nucleic Acid Amplification Tests (NAT)
16/104-001	Norovirus GII Working reagent for Nucleic Acid Amplification Techniques
16/110-001	Zika Virus Working Reagent for Nucleic Acid Amplification Testing (NAT)
16/124-001	Zika Virus run Control (NAT)